Gino Kenny

Teach:

32nd Dáil (2016 - )

Dáilcheantar:

Dublin Mid-West

Páirtí:

Solidarity - People Before Profit

Seoladh oifigiúil:

Leinster House

Kildare Street

Dublin 2

Sonraí teagmhála an Chomhalta

(01) 618 3817
(085) 721 1574

gino.kenny@oireachtas.ie

Member's Suíomh gréasáin | Facebook | Twitter

Óráidí le déanaí

Céad, 13 Márta 2019

Cannabis for Medicinal Use

Amharc

Déar, 7 Márta 2019

Local Drug and Alcohol Task Forces: Motion [Private Members]

Amharc

Céad, 20 Feabh 2019

Public Inquiries

Amharc

Féach ar níos mó óráidí ón gComhalta seo

Ceisteanna le déanaí

Céad, 13 Márta 2019

Cannabis for Medicinal Use
4. Deputy Gino Kenny asked the Minister for Health the steps he will take to address the issue of those with a licence to use cannabis medicinally having to travel to the Netherlands regularly to obtain their prescription; if the establishment of a distributive system similar to that in the UK and Northern Ireland (details supplied) will be considered; and if he will make a statement on the matter. [12082/19]

Amharc

Céad, 13 Márta 2019

Mental Health Services Provision
17. Deputy Gino Kenny asked the Minister for Health if his attention has been drawn to the fact that adult community mental health services in Clondalkin may be lost as a result of a lack of suitable premises; if his attention has been further drawn to the fact that organisations such as a task force (details supplied) are extremely concerned about the impact this will have on service users who benefit from having access to local services; if his attention has been further drawn to the fact that Clondalkin has one of the highest levels of referrals for mental health services in the country and the detrimental impact the loss of local mental health services will have on the community; the measures he will take to urge the HSE to ensure that services are kept in the locality; and if he will make a statement on the matter. [12399/19]

Amharc

Céad, 13 Márta 2019

Cannabis for Medicinal Use
66. Deputy Gino Kenny asked the Minister for Health if his attention has been drawn to, and his plans to address, the contradiction in granting licences for the prescription of THC products for children with intractable epilepsy but they are then omitted from the cannabis access programme; the steps he will take to include children with intractable epilepsy, with the recommendation of their consultant, in the cannabis access programme; and if he will make a statement on the matter. [12398/19]

Amharc